Zobrazeno 1 - 10
of 19
pro vyhledávání: '"IGF1 Deficiency"'
Autor:
Danielle Yaron-Saminsky, Karthik Nagaraj, Rive Sarfstein, Zvi Laron, Metsada Pasmanik-Chor, Haim Werner
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 21, p 11861 (2021)
The growth hormone (GH)–insulin-like growth factor-1 (IGF1) endocrine axis is a central player in normal growth and metabolism as well as in a number of pathologies, including cancer. The GH–IGF1 hormonal system, in addition, has emerged as a maj
Externí odkaz:
https://doaj.org/article/eeb9cb2ea6f449418f83d63753f81694
Autor:
Zvi Laron, Metsada Pasmanik-Chor, Rive Sarfstein, Danielle Yaron-Saminsky, Karthik Nagaraj, Haim Werner
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11861, p 11861 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences
Volume 22
Issue 21
The growth hormone (GH)–insulin-like growth factor-1 (IGF1) endocrine axis is a central player in normal growth and metabolism as well as in a number of pathologies, including cancer. The GH–IGF1 hormonal system, in addition, has emerged as a maj
Autor:
M J E Walenkamp, J.M. Wit
Publikováno v:
European Journal of Endocrinology, 181(6), C29-C33. BioScientifica Ltd.
Walenkamp, M J E & Wit, J M 2019, ' A homozygous mutation in the highly conserved Tyr60 of the mature IGF1 peptide broadens the spectrum of IGF1 deficiency ', European Journal of Endocrinology, vol. 181, no. 6, pp. C29-C33 . https://doi.org/10.1530/EJE-19-0801
European Journal of Endocrinology, 181(6), C29-C33
Walenkamp, M J E & Wit, J M 2019, ' A homozygous mutation in the highly conserved Tyr60 of the mature IGF1 peptide broadens the spectrum of IGF1 deficiency ', European Journal of Endocrinology, vol. 181, no. 6, pp. C29-C33 . https://doi.org/10.1530/EJE-19-0801
European Journal of Endocrinology, 181(6), C29-C33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d54764a163ea0f3bcaa389ac9be20f7
https://hdl.handle.net/1887/3195451
https://hdl.handle.net/1887/3195451
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Reviews of Physiology, Biochemistry and Pharmacology, Vol. 175 ISBN: 9783319952871
Non-communicable diseases, such as cardiovascular diseases, are the leading cause of mortality worldwide. For this reason, a tremendous effort is being made worldwide to effectively circumvent these afflictions, where insulin-like growth factor 1 (IG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85718ba8a48c9a997d27c1f996273dfc
https://doi.org/10.1007/112_2017_8
https://doi.org/10.1007/112_2017_8
Autor:
Laris Achlaug, Lena Lapkina-Gendler, Shoshana Yakar, Zvi Laron, Haim Werner, Danielle Yaron-Saminsky, Lina Somri, Karthik Nagaraj, Rive Sarfstein, Metsada Pasmanik-Chor
Publikováno v:
Cells, Vol 8, Iss 6, p 596 (2019)
Cells
Cells
Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency. The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical rele
Autor:
Dinesh Giri, Astrid Weber, Paul S. McNamara, Mohammed Didi, Matthew Peak, Senthil Senniappan, Brian F. Flanagan
Publikováno v:
Endocrine Abstracts.
Autor:
Zvi Laron
Publikováno v:
HORMONES. 7:24-27
Primary or secondary IGF1 deficiency has been implicated in shortening of lifespan. This paper reviews available data on the influence of IGF1 deficiency on lifespan and longevity in animals and man. It has been shown that inactivation of the IGF1 ge
Publikováno v:
Endocrine Abstracts.
Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies
Publikováno v:
European journal of endocrinology. 164(4)
ObjectiveTo investigate whether congenital IGF1 deficiency confers protection against development of malignancies, by comparing the prevalence of malignancies in patients with congenital (secondary) deficiency of IGF1 with the prevalence of cancer in